Workweek November 28, 2022
Happy Tuesday,
I was blown away by the reaction to my Twitter thread on the Mark Cuban Cost Plus Drugs Company. That’s probably the most viral I’ve been…ever.
Also, this is amazing:
On to this week’s healthcare news!
AMWELL IN TALKS TO ACQUIRE TALKSPACE FOR $1.50/SHARE
Amwell (not Awell) is potentially buying Talkspace for $1.50 / share, or $200M – an ~85% discount to Talkspace’s SPAC go-public price of $1.4B. Talkspace’s share price rose from $0.60 to $0.81 after the news dropped, so if you think this is legit, go make some arbitrage happen (not investment advice)! The acquisition talks are in “advanced” stages.
Context: Talkspace went public during the SPAC wave over the summer of 2021, merging with Hudson...
Today's Sponsors
Today's Sponsor